| Vol. 12.06 – 23 February, 2021 |
| |
|
|
| Single-cell gene expression profiling with parallel mutation detection demonstrated that the megakaryocyte-primed hematopoietic stem cells subpopulation expanded significantly with enhanced potential in untreated individuals with JAK2V617F+essential thrombocythemia, driven primarily by the JAK2 mutation and elevated interferon signaling. [Cell Stem Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists demonstrated that lysosomal equilibrative nucleoside transporter 3 (ENT3) transport of taurine-conjugated bile acids (TBA) facilitated TBA chemical chaperone function and alleviated endoplasmic reticulum stress in expanding mouse hematopoietic stem and progenitor cells. [Nature Communications] |
|
|
|
| Investigators showed that Z-DNA-binding protein 1 (ZBP1) was selectively expressed in late B cell development in both human and mouse cells and it was required for optimal T-cell-dependent humoral immune responses. [Haematologica] |
|
|
|
| Using unbiased global sequencing and directed genetic approaches focused on early mammalian development, the authors found that fetal liver macrophage exhibited a unique expression signature that differentiated them from erythroid and adult macrophage cells. [eLife] |
|
|
|
| Researchers demonstratef that the splenic microenvironment, specifically 15-PGDH high-expressing macrophages, megakaryocytes, and mast cells, regulated steady-state hematopoiesis and potentiated recovery after bone-marrow transplantation. [JCI Insight] |
|
|
|
| Scientists demonstrated that the overexpression of c-Myb and FoxM1 was responsible for the synergistic activation of the WNT5A promoter. [Scientific Reports] |
| |
|
|
| The safety and preliminary efficacy of venetoclax with low-dose navitoclax and chemotherapy was assessed in this Phase I dose escalation study in pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma. [Cancer Discovery] |
|
|
|
| By combining gene expression data from cell lines and patients with acute lymphoblastic leukemia, scientists observed that the model was useful for the classification of patients. [npj Precision Oncology] |
|
|
|
| Researchers revealed that the expression of miRNAs was aberrant and often heterogeneous in T cell prolymphocytic leukemia (T-PLL). They identified 35 miRNAs that were aberrantly expressed in T-PLL with miR-200c/141 as the most differentially expressed cluster. [Haematologica] |
|
|
|
|
| International collaborative clinical trials have led to better understanding of the underlying molecular biology, refined risk-based stratification, and investigated the use of hematopoietic stem cell transplantation. [Current Oncology Reports] |
|
|
|
| The authors discuss their approach to relapsed or refractory diffuse large B cell lymphoma patients and the open question of optimal sequencing of autologous transplant , CAR-T therapy, and bispecific antibodies. [Current Hematologic Malignancy Reports] |
|
|
|
|
| Dr. Salvatore Papa, an Assistant Professor in Cancer Research at the University of Leeds, has been awarded Leukaemia & Myeloma Research UK’s research grant to continue his specialist studies into examining how the accumulation of mutated proteins in certain blood cancer cells allows them to multiply repeatedly. [Charity Today] |
|
|
|
|
| March 24 – 25, 2021 Virtual |
|
|
|
|
|
| University of York – York, England, United Kingdom |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States |
|
|
|
| Icahn School of Medicine at Mount Sinai – New York, New York, United States |
|
|
|
| Blood Research Institute – Milwaukee, Wisconsin, United States |
|
|
|
|